Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells
- 1 April 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 407 (1), 1-6
- https://doi.org/10.1016/j.bbrc.2011.02.027
Abstract
No abstract availableKeywords
Funding Information
- National Laboratory of Medical Molecular Biology (2060204)
This publication has 29 references indexed in Scilit:
- Accumulation of driver and passenger mutations during tumor progressionProceedings of the National Academy of Sciences of the United States of America, 2010
- A small-cell lung cancer genome with complex signatures of tobacco exposureNature, 2009
- Evaluation of the 8q24 Prostate Cancer Risk Locus and MYC ExpressionCancer Research, 2009
- Synthetic lethal RNAi screening identifies sensitizing targets for gemcitabine therapy in pancreatic cancerJournal of Translational Medicine, 2009
- A high-throughput splinkerette-PCR method for the isolation and sequencing of retroviral insertion sitesNature Protocols, 2009
- A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal CancerScience, 2009
- A piggyBac transposon-based genome-wide library of insertionally mutated Blm-deficient murine ES cellsGenome Research, 2009
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Targeted therapies for pancreatic cancerBritish Medical Bulletin, 2008
- The Identification of MicroRNAs in a Genomically Unstable Region of Human Chromosome 8q24Molecular Cancer Research, 2008